Enalapril 依那普利
- Other names 別名：N/A
- Common Trade name(s) 常見牌子：Vasotec 悅寧定
- Usage 效用：Treats hypertension, myocardial infarction (heart attack), heart failure 控制高血壓、心肌梗塞、心臟衰竭
Drug labels and icon 藥物標籤及其圖標 : Take orally 口服 / Avoid taking in pregnancy 孕婦忌用
Introduction
Enalapril is an ACE (Angiotensin-Converting-Enzyme) inhibitor used to treat high blood pressure and heart failure primarily. It lowers blood pressure by reducing the narrowing of blood vessels.
Common side effects
Low blood pressure, dizziness, nausea, dry cough
Precautions
- Report the symptoms of angioedema (e.g. swelling of the face, lips, tongue or difficulty in breathing)
- Inform your doctor/pharmacist if you suffer from significant low blood pressure (fainting and lightheadedness) or consistent coughing
Who cannot take
- People with history of hereditary, idiopathic or ACEI-related angioedema
- People who took sacubitril within 36 hours
Cautions with other medicine/food
- Alcohol
- ARB such as losartan, valsartan (anti-hypertensives)
- Potassium supplements and potassium-sparing diuretics
- Nonsteroidal Anti-inflammatory drugs, such as Ibuprofen
- Allopurinol (reduce uric acid)
- Azathioprine, everolimus (Immunosuppressant)
- Lithium (antimanic agent)
- Heparins such as enoxaparin, tinzaparin (anticoagulants)
Pregnancy and breastfeeding
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
簡介
Enalapril是一隻血管張力素轉化酶抑制劑 (ACEI)，可用於控制高血壓及治療心臟衰竭。Enalapril通過減少血管收縮來達到降低血壓的效果。
常見副作用
低血壓，頭暈，噁心，乾咳
注意事項
- 如有血管水腫的症狀，例如臉部、嘴唇、舌頭腫起、呼吸困難，請告知你的醫生／藥劑師
- 如有嚴重低血壓或持續咳嗽的情況，請告知你的醫生／藥劑師
不可服用的人士
- 有遺傳性或特發性血管水腫病史的人
- 36小時內曾經服用sacubitril 的人
一同服用時需要注意的藥物／食物
- 酒精
- ARB ，如 losartan, valsartan （抗高血壓藥）
- 補鉀和保鉀利尿劑
- 非類固醇類消炎止痛藥，如布洛芬
- Allopurinol (降尿酸)
- Azathioprine, everolimus (降免疫力藥）
- Lithium (抗躁症藥)
- Heparins 如 enoxaparin, tinzaparin （抗凝血藥）
懷孕及哺乳
D：針對孕婦的控制實驗或觀察研究中，已證實此藥對胎兒有危險性。但在考量利弊得失下，此藥對於治療的利益可能大於潛在的危險性。